Streetbeat News

Price Targets

EVGO

RBC Capital analyst Chris Dendrinos has initiated coverage on EVgo (NASDAQ:EVGO) with a Sector Perform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 12:04 pm

CHPT

RBC Capital analyst Chris Dendrinos has initiated coverage on ChargePoint Holdings (NYSE:CHPT) with an Outperform rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 12:01 pm

RNR

Goldman Sachs analyst Yaron Kinar has initiated coverage on RenaissanceRe Holdings (NYSE:RNR) with a Buy rating and a price target of $242.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 12:00 pm

EG

Goldman Sachs analyst Alex Scott has initiated coverage on Everest Group (NYSE:EG) with a Buy rating and a price target of $449.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:59 am

AXS

Goldman Sachs analyst Alex Scott has initiated coverage on Axis Capital Holdings (NYSE:AXS) with a Sell rating and a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:58 am

ACGL

Goldman Sachs analyst Alex Scott has initiated coverage on Arch Capital Group (NASDAQ:ACGL) with a Neutral rating and a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:56 am

DOCN

B of A Securities analyst Wamsi Mohan has downgraded DigitalOcean Holdings (NYSE:DOCN) from Buy to Underperform and lowered the price target from $47 to $25.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:54 am

VIR

B of A Securities analyst Geoff Meacham has downgraded Vir Biotechnology (NASDAQ:VIR) from Buy to Neutral and lowered the price target from $23 to $14.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:53 am

ABM

Deutsche Bank analyst Faiza Alwy has downgraded ABM Industries (NYSE:ABM) from Buy to Hold and lowered the price target from $65 to $43.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:52 am

CLVT

Barclays analyst Manav Patnaik has downgraded Clarivate (NYSE:CLVT) from Equal-Weight to Underweight and lowered the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:31 am